4-(2,4,4-Trimethylpentan-2-yl)benzene-PEG4-OH, a nonionic surfactant with a low hydrophile-lypophile balance (HLB) value and dispersible in aqueous solution at room temperature, has a Krafft point above the room temperature. 4-(2,4,4-Trimethylpentan-2-yl)benzene-PEG4-OH has the potential for the research of the hepatitis C virus (HCV).

Product information

CAS Number: 2315-63-1

Molecular Weight: 382.53

Formula: C22H38O5

Chemical Name: 2-[2-(2-{2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy}ethoxy)ethoxy]ethan-1-ol

Smiles: CC(C)(C)CC(C)(C)C1C=CC(=CC=1)OCCOCCOCCOCCO

InChiKey: UYDLBVPAAFVANX-UHFFFAOYSA-N

InChi: InChI=1S/C22H38O5/c1-21(2,3)18-22(4,5)19-6-8-20(9-7-19)27-17-16-26-15-14-25-13-12-24-11-10-23/h6-9,23H,10-18H2,1-5H3

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: DMSO : 200 mg/mL (522.83 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO).

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 ^oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 ^oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vitro:

The SD minipool treatment is prepared using a 1:1 mixture of tri-n-butyl phosphate (TnBP) and 11-(4-tert-Octylphenoxy)-3,6,9-trioxaundecane-1-ol. SD treatment efficiently removes HCV infectivity from virus-containing plasma.

Products are for research use only. Not for human use.